Teleflex Incorporated (TFX): Price and Financial Metrics


Teleflex Incorporated (TFX)

Today's Latest Price: $363.22 USD

4.16 (1.16%)

Updated Oct 22 1:50pm

Add TFX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 142 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

TFX Stock Summary

  • TFX's went public 32.7 years ago, making it older than 89.31% of listed US stocks we're tracking.
  • Price to trailing twelve month operating cash flow for TFX is currently 40.43, higher than 90.99% of US stocks with positive operating cash flow.
  • The volatility of Teleflex Inc's share price is greater than that of only 6.06% US stocks with at least 200 days of trading history.
  • Stocks that are quantitatively similar to TFX, based on their financial statements, market capitalization, and price volatility, are COO, FTV, GNRC, PNR, and HRC.
  • TFX's SEC filings can be seen here. And to visit Teleflex Inc's official web site, go to www.teleflex.com.

TFX Stock Price Chart Interactive Chart >

Price chart for TFX

TFX Price/Volume Stats

Current price $363.22 52-week high $409.27
Prev. close $359.06 52-week low $221.27
Day low $357.41 Volume 47,750
Day high $366.16 Avg. volume 249,712
50-day MA $363.14 Dividend yield 0.38%
200-day MA $354.47 Market Cap 16.90B

Teleflex Incorporated (TFX) Company Bio


Teleflex Inc. designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company was founded in 1943 and is based in Wayne, Pennsylvania.

TFX Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$363.22$82.19 -77%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Teleflex Inc. To summarize, we found that Teleflex Inc ranked in the 17th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. The most interesting components of our discounted cash flow analysis for Teleflex Inc ended up being:

  • The company has produced more trailing twelve month cash flow than 64.7% of its sector Healthcare.
  • 87% of the company's capital comes from equity, which is greater than 71.98% of stocks in our cash flow based forecasting set.
  • Teleflex Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than just 0% of US stocks with positive free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-78%
1%-78%
2%-77%
3%-77%
4%-77%
5%-77%

Want more companies with a valuation profile/forecast similar to that of Teleflex Inc? See DHR, ICUI, ABC, EHC, and ZBH.


TFX Latest News Stream


Event/Time News Detail
Loading, please wait...

TFX Latest Social Stream


Loading social stream, please wait...

View Full TFX Social Stream

Latest TFX News From Around the Web

Below are the latest news stories about Teleflex Inc that investors may wish to consider to help them evaluate TFX as an investment opportunity.

FDA OKs expanded use of Teleflex Arrow EZ-IO

Teleflex (TFX) has received 510(k) clearance from the FDA to expand the Indications for Use of the Arrow EZ-IO Intraosseous Vascular Access System. The expanded indication states use of the device may be extended for up to 48 hours when alternate intravenous access is not available or reliably established in...

Seeking Alpha | October 1, 2020

Peripherally Inserted Central Catheters Market is forecast to reach USD 1.22 Billion by 2027 | R. Bard Inc., AngioDynamics, Inc., B. Braun Melsungen AG, Teleflex Incorporated, etc.

Reports and Data has recently added an investigative study report on the “Global Peripherally Inserted Central Catheters Market”. The report assesses the Peripherally Inserted Central Catheters Market with regards to the profit margin, value chain analysis, recent developments, opportunities, year-on-year

OpenPR | October 1, 2020

Global Coronary Angiography Devices Market (2019 to 2024) - Featuring Boston Scientific, Medtronic & Teleflex Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Coronary Angiography Devices Market" report has been added to ResearchAndMarkets.com's offering. This report was developed using extensive primary and secondary research by the publisher's analysts. Data from proprietary databases, proprietary market reports, company reports, import/export databases, and secondary data sources on medical device markets were used to develop estimates of the 2019 worldwide market size by product segment, ASPs, sales, and marke

Business Wire | September 3, 2020

Global Topical Absorbable Hemostats Market 2015-2030 (COVID-19's Impact) Featuring Ethicon, C. R. Bard, Baxter International, Pfizer, Braun Melsungen and Teleflex - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Topical Absorbable Hemostats (Wound Care Management) - Global Market Analysis and Forecast Model (COVID-19 market impact)" report has been added to ResearchAndMarkets.com's offering. This market model discusses in detail the impact of COVID-19 on Topical Absorbable Hemostats market for the year 2020 and beyond. Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To inc

Business Wire | August 26, 2020

2020 Global Market Study on External Pain Pumps - Players Include Medical Flow Systems, Smiths Medical & Teleflex Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global External Pain Pumps Market" report has been added to ResearchAndMarkets.com's offering. This report was developed using extensive primary and secondary research by the publisher's analysts. Data from proprietary databases, proprietary market reports, company reports, import/export databases, and secondary data sources on medical device markets were used to develop estimates of 2019 worldwide market size by product segment, ASPs, sales, and market share for t

Business Wire | August 24, 2020

Read More 'TFX' Stories Here

TFX Price Returns

1-mo 9.46%
3-mo -6.22%
6-mo 7.54%
1-year 13.36%
3-year 51.58%
5-year 196.71%
YTD -3.23%
2019 46.26%
2018 4.45%
2017 55.41%
2016 23.66%
2015 15.71%

TFX Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full TFX Dividend History

Continue Researching TFX

Want to see what other sources are saying about Teleflex Inc's financials and stock price? Try the links below:

Teleflex Inc (TFX) Stock Price | Nasdaq
Teleflex Inc (TFX) Stock Quote, History and News - Yahoo Finance
Teleflex Inc (TFX) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7847 seconds.